Connection

John Orak to Male

Back to Details
This is a "connection" page, showing publications John Orak has written about Male.
John Orak
Connection Strength
0.099
Male
  1. Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr. 2010 Jul; 157(1):132-7.
    View in: PubMed
    Score: 0.019
  2. Manganese superoxide dismutase in rat liver peroxisomes: biochemical and immunochemical evidence. Mol Cell Biochem. 1999 Jul; 197(1-2):7-12.
    View in: PubMed
    Score: 0.009
  3. Acquired free protein S deficiency in children with steroid resistant nephrosis. Ann Clin Lab Sci. 1996 May-Jun; 26(3):279-82.
    View in: PubMed
    Score: 0.007
  4. Masked hypertension is prevalent in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2013 Jan; 28(1):115-20.
    View in: PubMed
    Score: 0.006
  5. Graft outcomes in pediatric kidney transplantation: focus on the role of race. Saudi J Kidney Dis Transpl. 2012 Jul; 23(4):684-92.
    View in: PubMed
    Score: 0.006
  6. Acute peritoneal dialysis utilizing a non-luminal channeled catheter in infants. Adv Perit Dial. 1992; 8:429-32.
    View in: PubMed
    Score: 0.005
  7. A critical analysis of racial difference with mycophenolate mofetil (MMF) dosing, clinical outcomes and adverse effects in pediatric kidney transplant patients. Clin Transplant. 2011 Jul-Aug; 25(4):534-40.
    View in: PubMed
    Score: 0.005
  8. Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol. 2010 Aug; 25(8):1505-11.
    View in: PubMed
    Score: 0.005
  9. Attenuation of ischemia-reperfusion injury in a canine model of autologous renal transplantation. Transplantation. 2004 Sep 15; 78(5):654-9.
    View in: PubMed
    Score: 0.003
  10. Control of hypertension by ethanol renal ablation. Radiology. 1983 Jul; 148(1):51-4.
    View in: PubMed
    Score: 0.003
  11. Attenuation of renal ischemia/reperfusion injury by a triple drug combination therapy. J Nephrol. 2003 Jan-Feb; 16(1):63-74.
    View in: PubMed
    Score: 0.003
  12. Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia-reperfusion injury in rat kidney. Mol Cell Biochem. 2002 Nov; 240(1-2):9-17.
    View in: PubMed
    Score: 0.003
  13. Attenuation of ischemia/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon. Mol Cell Biochem. 2002 Nov; 240(1-2):19-29.
    View in: PubMed
    Score: 0.003
  14. Kidney ischemia-reperfusion: modulation of antioxidant defenses. Mol Cell Biochem. 2000 Feb; 205(1-2):1-11.
    View in: PubMed
    Score: 0.002
  15. Studies on hepatic injury and antioxidant enzyme activities in rat subcellular organelles following in vivo ischemia and reperfusion. Mol Cell Biochem. 1997 Nov; 176(1-2):337-47.
    View in: PubMed
    Score: 0.002
  16. Tissue differences in antioxidant enzyme gene expression in response to endotoxin. Free Radic Biol Med. 1996; 21(4):533-40.
    View in: PubMed
    Score: 0.002
  17. Demonstration of glutathione peroxidase in rat liver peroxisomes and its intraorganellar distribution. Arch Biochem Biophys. 1994 Dec; 315(2):331-8.
    View in: PubMed
    Score: 0.002
  18. Antioxidant enzymes in ciprofibrate-induced oxidative stress. Carcinogenesis. 1994 Sep; 15(9):1923-30.
    View in: PubMed
    Score: 0.002
  19. Extrinsic compression in the iliac fossa can cause renal vein occlusion in pediatric kidney recipients but graft loss can be prevented. Transplant Proc. 1994 Feb; 26(1):119-20.
    View in: PubMed
    Score: 0.002
  20. Alterations of peroxisomal function in ischemia-reperfusion injury of rat kidney. Biochim Biophys Acta. 1993 Oct 20; 1182(3):291-8.
    View in: PubMed
    Score: 0.002
  21. Expression of antioxidant enzymes in rat kidney during ischemia-reperfusion injury. Mol Cell Biochem. 1993 Aug 25; 125(2):97-104.
    View in: PubMed
    Score: 0.001
  22. Ischemia-reperfusion injury: biochemical alterations in peroxisomes of rat kidney. Arch Biochem Biophys. 1992 May 15; 295(1):90-100.
    View in: PubMed
    Score: 0.001
  23. Demonstration of Cu-Zn superoxide dismutase in rat liver peroxisomes. Biochemical and immunochemical evidence. J Biol Chem. 1992 Apr 05; 267(10):6870-3.
    View in: PubMed
    Score: 0.001
  24. Lipid peroxidation and oxidation of lignoceric acid in kidneys from thioridazine treated rats. J Exp Pathol. 1990; 5(4):177-86.
    View in: PubMed
    Score: 0.001
  25. Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study. Am J Dis Child. 1988 Sep; 142(9):985-8.
    View in: PubMed
    Score: 0.001
  26. Fatty acid metabolism in renal ischemia. Lipids. 1988 Sep; 23(9):882-4.
    View in: PubMed
    Score: 0.001
  27. Use of a bleeding time determination in the evaluation of unexplained hematuria. J Urol. 1987 Mar; 137(3):527-8.
    View in: PubMed
    Score: 0.001
  28. Continuous ambulatory peritoneal dialysis in a program for children with end stage renal disease. Eur J Pediatr. 1984 Aug; 142(3):174-8.
    View in: PubMed
    Score: 0.001
  29. Total parathyroidectomy and autotransplantation for tertiary hyperparathyroidism in children with chronic renal failure. J Pediatr Surg. 1984 Aug; 19(4):389-93.
    View in: PubMed
    Score: 0.001
  30. Growth in children with various therapies for end-stage renal disease. Am J Dis Child. 1984 Jan; 138(1):28-31.
    View in: PubMed
    Score: 0.001
  31. Continuous ambulatory peritoneal dialysis in a pediatric population. Am J Dis Child. 1983 Apr; 137(4):388-92.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.